» Articles » PMID: 24954327

Clinical Characteristics of Asthma Combined with COPD Feature

Overview
Journal Yonsei Med J
Specialty General Medicine
Date 2014 Jun 24
PMID 24954327
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: In clinical practice, some patients with asthma show incompletely reversible airflow obstruction, resembling chronic obstructive pulmonary disease (COPD). The aim of this study was to analyze this overlap phenotype of asthma with COPD feature.

Materials And Methods: A total of 256 patients, over the age of 40 years or more with a diagnosis of asthma, based on either 1) positive response to bronchodilator: >200 mL forced expiratory volume in 1 s (FEV₁) and >12% baseline or 2) positive methacholine or mannitol provocation test, were enrolled. Among the asthma patients, we defined the overlap group with incompletely reversible airflow obstruction [postbronchodilator FEV₁/forced vital capacity (FVC)<70] at the initial time of admission and continuing airflow obstruction after at least 3 months follow up. We evaluated clinical features, serum eosinophil counts, serum total immunoglobulin (Ig) E with allergy skin prick test, spirometry, methacholine or mannitol provocation challenges and bronchodilator responses, based on their retrospective medical record data. All of the tests mentioned above were performed within one week.

Results: The study population was divided into two groups: asthma only (62%, n=159, postbronchodilator FEV₁/FVC≥70) and overlap group (38%, n=97, postbronchodilator FEV₁/FVC<70). The overlap group was older, and contained more males and a higher percentage of current or ex-smokers than the asthma only group. Significantly lower FEV₁ and higher total lung capacity, functional residual capacity, and residual volume were observed in the overlap group. Finally, significantly lower serum eosinophil count and higher IgE were seen in the overlap group.

Conclusion: Our results showed that the overlap phenotype was older, male asthmatic patients who have a higher lifetime smoking intensity, more atopy and generally worse lung function.

Citing Articles

Clinical Indicators for Asthma-COPD Overlap: A Systematic Review and Meta-Analysis.

Peng J, Wang M, Wu Y, Shen Y, Chen L Int J Chron Obstruct Pulmon Dis. 2022; 17:2567-2575.

PMID: 36259043 PMC: 9572492. DOI: 10.2147/COPD.S374079.


Status of Studies Investigating Asthma-Chronic Obstructive Pulmonary Disease Overlap in Korea: A Review.

Jo Y Tuberc Respir Dis (Seoul). 2021; 85(2):101-110.

PMID: 34871477 PMC: 8987665. DOI: 10.4046/trd.2021.0140.


Update on Asthma-COPD Overlap (ACO): A Narrative Review.

Mekov E, Nunez A, Sin D, Ichinose M, Rhee C, Jose Maselli D Int J Chron Obstruct Pulmon Dis. 2021; 16:1783-1799.

PMID: 34168440 PMC: 8216660. DOI: 10.2147/COPD.S312560.


The Prevalence of Asthma-COPD Overlap (ACO) Among Patients with Asthma.

Sevimli N, Yapar D, Turktas H Turk Thorac J. 2019; 20(2):97-102.

PMID: 30958980 PMC: 6453626. DOI: 10.5152/TurkThoracJ.2018.18055.


Inflammatory Cytokines and T-Lymphocyte Subsets in Serum and Sputum in Patients with Bronchial Asthma and Chronic Obstructive Pulmonary Disease.

Bai Y, Zhou Q, Fang Q, Song L, Chen K Med Sci Monit. 2019; 25:2206-2210.

PMID: 30908476 PMC: 6442499. DOI: 10.12659/MSM.913703.


References
1.
Kim T, Oh Y, Chang Y, Cho Y, Jang A, Cho S . The reality of an intermediate type between asthma and COPD in practice. Respir Care. 2012; 57(8):1248-53. DOI: 10.4187/respcare.01232. View

2.
Sears M, Burrows B, Flannery E, Herbison G, Hewitt C, Holdaway M . Relation between airway responsiveness and serum IgE in children with asthma and in apparently normal children. N Engl J Med. 1991; 325(15):1067-71. DOI: 10.1056/NEJM199110103251504. View

3.
Miravitlles M, Soriano J, Ancochea J, Munoz L, Duran-Tauleria E, Sanchez G . Characterisation of the overlap COPD-asthma phenotype. Focus on physical activity and health status. Respir Med. 2013; 107(7):1053-60. DOI: 10.1016/j.rmed.2013.03.007. View

4.
Crapo R, Casaburi R, Coates A, Enright P, Hankinson J, Irvin C . Guidelines for methacholine and exercise challenge testing-1999. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. Am J Respir Crit Care Med. 2000; 161(1):309-29. DOI: 10.1164/ajrccm.161.1.ats11-99. View

5.
Lee J, Haselkorn T, Borish L, Rasouliyan L, Chipps B, Wenzel S . Risk factors associated with persistent airflow limitation in severe or difficult-to-treat asthma: insights from the TENOR study. Chest. 2007; 132(6):1882-9. DOI: 10.1378/chest.07-0713. View